Skip to main content

AlloVir to Present at Upcoming Investor Conferences

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

AlloVir, Inc. (Nasdaq: ALVR), a late-clinical stage allogeneic T cell immunotherapy company, today announced that Diana Brainard, M.D., Chief Executive Officer, will participate in the following upcoming investor conferences:

Morgan Stanley 21st Annual Global Healthcare Conference

Fireside Chat: Monday, September 11, 2023 at 4:55 pm ET

H.C. Wainwright 25th Annual Global Investment Conference

Presentation: Tuesday, September 12, 2023 at 12:00 pm ET

A live webcast and archived replay of these presentations will be available on the Investors & Press section of the AlloVir website at https://ir.allovir.com.

About AlloVir

AlloVir is a leading late-clinical stage cell therapy company focused on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company's innovative and proprietary technology platform leverages off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir's technology and manufacturing process enable the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio. For more information, visit www.allovir.com or follow us on Twitter/X or LinkedIn.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  267.84
+0.10 (0.04%)
AAPL  348.06
-4.39 (-1.25%)
AMD  490.08
-40.06 (-7.56%)
BAC  48.68
-0.23 (-0.47%)
GOOG  286.00
+6.80 (2.44%)
META  615.62
-0.76 (-0.12%)
MSFT  516.03
+7.74 (1.52%)
NVDA  152.09
+1.13 (0.75%)
ORCL  113.62
-0.27 (-0.23%)
TSLA  380.21
-3.51 (-0.91%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.